Loss of SMN Impairs Osteoblast–Osteoclast Coupling via IGF1 –Akt– OPG Axis in Spinal Muscular Atrophy

Oct 13, 2025FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Loss of SMN May Disrupt Bone-Building and Bone-Breaking Cell Interaction Through IGF1-Akt-OPG Pathway in Spinal Muscular Atrophy

AI simplified

Abstract

SMA mice exhibited significant bone mass reduction characterized by impaired bone formation and increased bone resorption.

  • Osteogenesis was impaired, while osteoclastogenesis was increased in SMA mice.
  • In vitro findings showed suppressed osteoclast differentiation from bone marrow-derived macrophages in SMA mice, contrasting with in vivo results.
  • Osteoclast hyperactivity was linked to decreased osteoblast-derived (OPG), driven by local (IGF1) deficiency.
  • SMN protein loss led to IGF1 downregulation, which inhibited the PI3K-Akt signaling pathway and reduced OPG expression.
  • Exogenous OPG administration mitigated osteoclast differentiation and promoted osteoblast function, partially restoring bone formation.

AI simplified

Key numbers

60%
Decrease in
Measured in 3-month-old mice vs. control mice.
Not specified
Increase in RANKL/ Ratio
Observed in mice compared to controls.

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free